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Having a severe mental illness (SMI) is associated
with having compromised physical health. Although
SMI can be regarded as an imprecise diagnosis the
concept of SMI is a clinical one and is included in
many government policy documents and other
bodies. Life expectancy in schizophrenia is 20% lower
than in the general population (1) and two-thirds of
the excess mortality seen in the schizophrenia patient
population is attributable to natural (predominantly
cardiovascular and respiratory) causes (2,3). Intrinsic
risk factors, such as age, familial traits or ethnicity,
increase an individual’s vulnerability to physical
illness, but it is also evident that people with SMI are
more likely to have lifestyles which increase their risk
of preventable physical disease (4–6). Such lifestyle
factors include smoking, obesity, poor diet, lack of
exercise and poverty (4,5,7,8). Some of the excess
mortality seen in SMI might be reduced if attention
were paid to these modiﬁable risk factors.
Evidence suggests that these risk factors for physi-
cal illness are not routinely measured in this popula-
tion in the UK. A review of screening for
dyslipidaemia in 606 patients in UK found that lipid
screening had been undertaken in only 3.5% of
patients with SMI taking antipsychotics (9). Further-
more there appear to be very few services designed
to tackle the high level of physical health problems
seen in this group. Patients with SMI may not pro-
actively attend their GP for healthcare and such
healthcare is not always proactively offered by GPs.
Kendrick (10) found that despite presenting to pri-
mary care services three to four times more fre-
quently than the general population, physical health
risk factors in patients with SMI were rarely moni-
tored by GPs. Thus, despite the recognition that
there is an increased prevalence of risk factors for
cardiovascular disease (CVD) in this population,
there is little routine recording of blood pressure,
weight, glucose or lipid screening, either in primary
or secondary care services. Not much evidence exists
of services that might provide smoking cessation or
dietary improvements. However, the evidence sug-
gests that when health screening from a GP is
offered patients will accept. A recent UK study
reported that a similar number of patients with psy-
chosis accepted a postal invitation to undergo
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SUMMARY
Introduction: Patients with severe mental illness (SMI) have higher rates of car-
diovascular disease (CVD) morbidity and mortality than the general population. In
the UK, data were limited regarding the known prevalence of physical health
screening of SMI patients. Aims: A total of 966 patients with SMI from seven
geographically varied regions in the UK agreed to participate in a 2-year nurse-led
intervention (Well-being Support Programme), designed to improve their overall
physical health by providing basic physical health checks, health promotion advice,
weight management and physical activity groups in secondary care. Results: At
baseline, only 31% of participants had undergone a recent physical health check.
There were high rates of obesity (BMI > 30 in 49%), glucose abnormalities
(12.4%), hypertension/prehypertension (50%), hyperlipidaemia (71%), poor diet
(32%), low exercise levels (37.4%) and smoking (50%). Conclusions: Patients
with SMI where healthcare professionals have concerns regarding their physical
health, have potentially modiﬁable risk factors for CVD, which remain undiag-
nosed. Programmes designed to address the physical health problems in SMI need
to be implemented and evaluated in this already marginalised group of people.
What’s known
Severe mental illness (SMI) is associated with a
variety of medical illness found in excess in
comparison to a general population. Much of these
physical illness data is derived from outside UK and
is focussed on selected cardiovascular risk factors.
What’s new
Most SMI patients in the UK have risk factors for
signiﬁcant physical illness including overweight,
smoking, low activity levels and poor diet. The
provision of physical health checks varies across the
UK with an average of 31% SMI patients getting a
yearly review. SMI patients need targeted physical
health programmes to address common modiﬁable
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chotic patients (11).
The overall evidence from a complete review of
lifestyle management studies is that most patients
will accept entry into an appropriate programme (8).
There are clear beneﬁts of physical health interven-
tions being available at any point of contact with a
healthcare professional, not only with the GP. People
with SMI are often in regular contact with a mental
health team, yet many do not have regular contact
with primary care services.
Any physical health improvement intervention
should target not only weight but also diet, smoking,
exercise levels, dietary choices and be primarily edu-
cational and long term. The issue is not so much
whether it should be done or who should be respon-
sible for delivering it, but when and how and the
optimum type of programme.
The Well-Being Support programme in the UK
has been running for 2 years. The UK government
recently endorsed this programme and its aims
(12). This paper focusses on the demographics and
the degree of baseline physical pathology in a large
geographically diverse group of patients with SMI,
who entered the WSP due to healthcare profes-
sional concern regarding their physical health mon-
itoring.
Method
A total of 966 outpatients with SMI (> 2 years) were
enrolled in the WSP. All patients who joined the
programme signed consent forms agreeing to basic
physical health checks, lifestyle advice and if appro-
priate to participate in healthy living groups. They
also consented to anonymised data being used to
form the basis of an evaluation of this service. Ethi-
cal approval was not sought as the WSP is not an
intervention as such but provided a service relevant
for SMI patients in secondary care. Such care for
non-mentally ill subjects would usually be provided
in primary care.
WSP implementation
Seven Mental Health Trusts from around England
and Wales took part in the service, encompassing a
wide geographical and socio-economic spread, from
inner city and rural-deprived areas to more afﬂuent
suburban areas. At each centre, a registered mental
nurse, trained in monitoring the physical health of
people with SMI worked with a lead psychiatric con-
sultant. Full details of WSP have previously been
published (13). In summary, a register of patients
with SMI (schizophrenia, schizoaffective and severe
affective disorders) was set up by the nurse in con-
junction with local care-coordinators and these
referred patients invited to enrol in the programme.
The care-coordinators were asked to refer patients
with SMI who may beneﬁt from inclusion in the
WSP. The cohort thus should be considered an SMI
cohort where concern existed regarding their physical
health monitoring or status. A few patients self-
referred and referrals were also accepted from local
psychiatrists. Data was not available on the patients
declining enrolment in the programme nor on the
precise diagnoses of the enrolled patients. Local gen-
eral practitioners were informed of the service and
the majority signed up to shared care agreements
thus facilitating communication of information
regarding the physical health of these patients. For
those patients without a GP, the nurse adviser would
work with the local community mental health team
(CMHT) to get the patient registered. For those
patients who required primary care intervention,
who had minimal contact with their GP, the nurse
adviser would facilitate their attendance at the GP
surgery for an appointment.
Details of the WSP
Each enrollee was asked to attend for a minimum of
six consultations over a maximum of 2 years. The
WSP was divided into key steps.
Step 1: A register of SMI patients was generated
and these patients were invited to attend the Well-
being Support Programme. The nurse adviser set up
a weight management and physical activity group in
the setting of their choice (usually the community
mental health team base or the local GP practice)
that continued throughout the 2 years of the pro-
gramme.
Step 2: First consultations involved a basic physical
health check (BP, pulse, weight and height), assess-
ment of lifestyle (diet, physical activity, smoking
rates) and medication side effects (Liverpool Univer-
sity Side Effect Rating Scale, LUNSERS) (14).
The nurse advisers were trained in assessing physi-
cal health risk factors. They rated the responses to a
series of questions regarding type of diet and amount
and quality of exercise and the presence of previous
physical health checks.
Patients were asked as to whether they had been
having regular physical health checks undertaken by
their general practitioner, psychiatrist or other. The
time-scale utilised was at any time during the previ-
ous 12 months. The question asked was ‘Have you
been receiving regular physical health checks or
advice? For example blood pressure, pulse monitor-
ing or checks for diabetes?’
Diet and activity were assessed by self-report using
Likert type scales with categorical responses:
1972 Well-being baseline
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The nurse would rate the patient’s diet based on
how they described the foods and ﬂuids they had
consumed in the last few days and asking them if
this fairly represented their eating habits. These rat-
ings were based on how the person described their
diet in terms of eating pattern, food choice and
cooking methods. Nurses would initially ask patients
to rate their own diet. Patients with unhealthy diets
would often consider their diet to be healthy. This
helped as a starting point in terms of educational
needs around healthy eating.
• Healthy diet was assessed using established princi-
ples of nutrition (regular meals and drinks, daily con-
sumption of calories, low sugar, low fat diet and high
in varied ﬁbre types). Examples of such advice
include ‘Wired for Health’, a UK government spon-
sored education programme (15). An example might
be a diet consisting of ﬁve portions of fruit and vege-
tables, a third carbohydrates and the ﬁnal-third an
admixture of protein, dairy foods and some fats (15).
The diet should be generally low in sugar, low in fat
and high in ﬁbre. Calorie intake would approximate
to < 2000 kcal (females) and < 2500 kcal (males).
Meals would be eaten three times/day and there
would not be a dominance of ‘fast food’.
• Average diet probably had the most variables –
this could be higher in fat, regular meals but most
likely overeating, probably over eating fats and sugars
and under eating fruits and vegetables. The most
common example would include excess calorie intake
on 1–2 days each week and ‘fast-food’ as predomi-
nant meals 1–2 days each week.
• Unhealthy – irregular eating pattern, poor nutri-
tional content, excess of sweets and crisps, and many
high fat foods (fast food). These diets would consist
often of predominant meals not cooked at home but
high-fat ‘fast food’ and an absence of fresh fruit and
vegetables
(B) Activity, which resulted in sweating and slight
breathlessness, was designated as exercise. Speciﬁc
questions were asked regarding walking, running,
game sports, swimming, gym and other. Duration
was recorded in minutes. The nurses rated the
amount of such activity per week.
Step 3: The second consultation covered a discus-
sion of the results of the LUNSERs, blood tests (ran-
dom blood glucose, thyroid function, liver function,
prolactin, lipid screen and any other measures at the
request of the treating clinician).
Step 4: An individual patient could undergo any
one or more of the following as required:
(i) Referral to a group for weight management or
physical activity;
(ii) Referral to GP for further physical health care
(via psychiatrist);
(iii) Referral to specialist for further physical health
care (via psychiatrist);
(iv) Change of medication (by psychiatrist).
Thus in addition to these individual consultations,
the nurse adviser provided access to Healthy Living
and/or Weight Management groups and physical
activity groups. The structure of the groups varied
between different sites. Some nurses offered separate
weight management groups, in other areas, these
were included as part of the healthy living group.
The groups were mostly run by the same nurse advi-
ser, however, in some areas appropriate groups
already in existence were used.
Statistical analysis
As the data is derived from an audit, descriptive data
is presented to include mean values and standard
deviations where appropriate. Spearman’s rho corre-
lation coefﬁcient was used to assess relationships
between different variables. Statistical analyses were
done using spss v. 12 for Windows (SPSS Inc., Chi-
cago, IL, USA).
Results
A total of 966 patients enrolled in the programme,
10 patients were excluded from the analysis because
of unreliable data. The demographic breakdown of
the remaining 956 patients can be seen in Table 1.
The average age of the cohort was 46.6, however,
42% were aged over 49 years.
Table 1 Baseline demographics
National audit Male (%) Female (%)
Total
numbers (%)
Total numbers 489 (51) 467 (49) 956 (100)
Age < 30 49 (10.0) 26 (5.5) 75 (7.9)
30–39 117 (23.9) 97 (20.7) 214 (22.4)
40–49 135 (27.6) 133 (28.4) 268 (28)
> 49 188 (38.5) 211 (45.4) 399 (41.7)
Ethnicity
White Caucasian 826 (86.4)
White European 5 (0.5)
Black Caribbean 26 (2.7)
Black African 19 (2.0)
Black British 32 (3.4)
Mixed black/white 5 (0.5)
Southeast Asian 40 (4.2)
Far East Asian 3 (0.3)
Well-being baseline 1973
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31% of the patients had undergone regular physical
health checks during the previous year, although
there was a wide variation across the seven geograph-
ical locations that ranged from 7% to 49% (Figure 1).
In our cohort of 966 patients, 92% received individ-
ual weight management as part of the routine nurse
consultations, 51% were also referred to a weight
management group and 47% to a physical activity
group.
Mean BMI was 31 and 81% had a BMI > 25, 49%
had a BMI > 30 indicating obesity and 24% had a
BMI > 35 indicating morbid obesity (Table 2). Sig-
niﬁcantly more females had BMI > 35 than males
(30% vs. 18%; p < 0.01).
Blood pressure measurements were available for
890 of the sample. Mean blood pressure was 132/82
in this group (Table 3). Slightly <50% of the group
had a normal blood pressure. 21% were prehyperten-
sive, 29% had grade 1 or more hypertension and
2.0% had severe hypertension (Table 4).
The patients in this sample smoked an average of
13.4 cigarettes per day and 50% smoked on a daily
basis. Of these 479, 90% smoked more than 10
cigarettes per day and 78% smoked more than 20




















Figure 1 Physical health checks at baseline
Table 2 BMI at baseline
BMI
All (n = 893) Female (n = 438) Male (n = 455)
% n % n % n
Underweight < 18 0 0 0 0 0 0
Normal 18–25 19 174 18 79 21 95
Overweight 26–30 32 283 28 124 35 159
Obese (class 1) 31–35 25 223 24 105 26 118
Obese (class 2) > 35 24 213 30 130 18 83
Table 3 Mean ﬁndings at baseline
Baseline Mean (SD) Range
Age, n ¼ 956 46 18–77
BMI, n ¼ 893 31.2 (6.7) 18–59
Cigarettes, n ¼ 956 13.4 (15.0) Range 0–60
Alcohol (units), n ¼ 956 7.2 (16.8) 0–168








Activity (min), n ¼ 956 57 (61.1) 0–180
Diet, n ¼ 956 36.4 (25.1) 0–100
Random glucose (mmol/l), n ¼ 714 6.1 (2.8) 2.5–28.9
HbA1c, n ¼ 188 5.7 (1.5) 4.1–13.9
Triglyceride, n ¼ 209 (mmol/l) 2.3 (1.3) 0.6–6.4
HDL cholesterol, n ¼ 209 (mmol/l) 1.2 (0.5) 0.57–4.7
AST, n ¼ 345 (IU/l) 25.1 (13.7) 9–151
ALT, n ¼ 828 (IU/l) 29.3 (18.5) 6–131
Alkaline phosphatase, n ¼ 832 (IU/l) 118.8 (71.7) 13–568
Gamma GT, n ¼ 569 (IU/l) 49.6 (71.6) 8–1112
Total bilirubin, n ¼ 834 (lmol/l) 8.7 (4.3) 2–40
Albumin, n ¼ 834 (g/l) 42.3 (3.5) 26–53
Prolactin, n ¼ 535 (IU/l) 548 50–3349
TSH, n ¼ 459 (IU/l) 2.3 (3.3) 0.01–54.7
Free T4, n ¼ 459 (pmol/l) 15.0 (3.3) 1.5–32.5
1974 Well-being baseline
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(Table 5). However, 31% did the recommended
90 min or more of exercise per week. 35% of
the patients drank alcohol, with 11% taking more
than 21 units/week and 2% taking more than
60 units/week.
Only 16% of the patients had a good dietary habit
(Table 5). 52% had an average score for dietary habit
with 32% having a very poor dietary habit.
Blood samples were taken in a non-fasting state.
Random glucose measures showed that 12.4% of the
sample had a blood glucose > 7.1 mmol/l and 5.5%
> 11 mmol/l. 71% had abnormal lipids; the mean tri-
glyceride level was 2.3 mmol/l. Mean HDL cholesterol
was 1.2 mmol/l. 31.6% were hyperprolactinaemic
(prolactin > 500 IU/l) with 5% having a prolactin
> 2000 IU/l. 50% had abnormal liver enzymes (50%
raised alkaline phosphatase, 19% raised gamma-
glutamyl transpeptidase (GT), 3% raised aspartate
aminotransferase (AST), and 26% raised alanine
transaminase (ALT)). Mean glycosylated haemoglobin
(HbA1c) was 5.7% and 35.7% had an HbA1c > 5.7.
Normal ranges were deﬁned as those of each local
laboratory who performed the testing. BMI was
signiﬁcantly associated with diastolic blood pressure
(r ¼ 0.08, p < 0.05). There was a highly signiﬁcant
negative association between BMI and diet
(r ¼ )0.22, p < 0.001); BMI and level of activity
(r ¼ )0.17, p < 0.001) and BMI and alcohol
intake (r ¼ )0.12, p < 0.001). When age was con-
trolled for, BMI continued to be associated with dia-
stolic blood pressure (DBP) (r ¼ 0.08, p < 0.05). BMI
continued to be negatively associated with diet (r ¼
)0.22, p < 0.001), alcohol (r ¼ )0.11, p < 0.01) and
level of activity (r ¼ )0.17, p < 0.001). Hence, being
overweight was associated with having a higher blood
pressure, a poorer diet and less exercise. It is of note
that activity was also negatively associated with DBP
(r ¼ )0.08, p < 0.05) and heart rate (r ¼ )0.07, p <
0.05) but positively associated with diet (r ¼ 0.16,
p < 0.001). Thus more active individuals had lower
blood pressure, lower heart rates and better diets.
Discussion
A total of 966 patients with SMI enrolled in the
Well-being Support Programme. Prior to entering
the programme, only 31% had received any kind of
regular physical health checks and this ﬁgure was
highly variable regionally. Our data has shown a high
prevalence of potentially modiﬁable physical health
risk factors in this group of patients. One of our
aims was to establish the likely physical health state
of a routine population of SMI patients in the UK.
The relationships between the risk factors were simi-
lar to those we would expect to see in the general
population, however, the effects of the progression of
the illness, lifestyle, poor dietary choices and poverty
combined with psychotropic treatments may sub-
stantially increase their risk of CVD in the absence of
any intervention (16).
The WSP was designed as an intervention that
may beneﬁt SMI patients regardless of diagnosis and
medication status. Data was thus not collected on
speciﬁc diagnosis and medication and this is a signif-
icant limitation of the data and its extrapolation.
Any role of medication or diagnosis on these mea-





pressure (mmHg) Count (%)
Normal BP < 130 < 85 442 (49.7)
High-normal BP 130–139 85–89 189 (21.2)
Grade 1 hypertension (mild) 140–159 90–99 196 (22.0)
Grade 2 hypertension (moderate) 160–179 100–109 46 (5.2)
Grade 3 hypertension (severe) ‡ 180 ‡ 110 17 (1.9)
Isolated systolic hypertension (grade 1) 140–159 < 90 111 (12.5)
Isolated systolic hypertension (grade 2) ‡ 160 < 90 20 (2.2)
Table 5 Quality of diet and activity at baseline
Cigarette smoking n ¼ 956
Smoker 479 (50%)
Non-smoker 478 (50%)
Alcohol n ¼ 956
Alcohol (any consumption) 334 (35%)
No current alcohol 622 (65.1%)
Activity n ¼ 956
No regular exercise 358 (37.4%)
Diet n ¼ 956
Poor diet 304 (32%)
Moderate diet 502 (52%)
Good diet 150 (16%)
Well-being baseline 1975
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this audit.
Most of the group were overweight, with 49%
being in the obese range and 24% of the group were
severely obese. Females in particular had a signiﬁ-
cantly increased propensity for BMI > 30 compared
with males (30% vs. 18%; p < 0.01). Obesity is one
of the traditional risk factors for CVD (16). In this
group, BMI was signiﬁcantly correlated to poor diet,
lack of exercise and raised DBP. This is an important
correlation in terms of potentially being able to
address these signiﬁcant CVD risk factors through
the WSP and similar programmes. Paton found that
weight had been recorded in routine practice in 19%
of SMI patients (9). In addition to obesity other
major CVD risk factors were prevalent. Using the
British Hypertension Society 2004 guidelines (17)
only 50% of this cohort was found to have a normal
blood pressure. 29% had hypertension and an addi-
tional 21% had high-normal (prehypertension) blood
pressure that might be reduced by lifestyle changes.
The CATIE study of schizophrenia patients with fast-
ing laboratory parameters (693 patients) report a
higher prevalence of hypertension (47%) in categori-
cal terms (18) yet lower mean BP values than in our
audit. CATIE also reports BP data in comparison
with the USA general population (NHANES). The
clear ﬁndings in CATIE were that female schizophre-
nia patients have a particular propensity for BP ele-
vation compared with a matched control population.
Dyslipidaemia was frequent in this group (71%)
and rates were consistent with those found in other
SMI populations. Paton reported hyperlipidaemia
was present in 68% of her sample of SMI patients
(9). Blood samples, however, were not fasting sam-
ples. Fasting lipids provide a greater degree of accu-
racy and non-fasting triglyceride values are essentially
invalid. CATIE reports that hyperlipidaemia criteria
for the metabolic syndrome were met in 42–50% for
triglycerides and 49–63% for HDL in fasting samples
(18). Figures were substantially lower in the control
populations in NHANES indicating that hyperlipida-
emia is more prevalent in an SMI population. This
was a particular ﬁnding also in females who had
twice the likelihood of hyperlipidaemia.
We found that 12.4% of the sample had a random
glucose test > 7.1 nmol/l. Of these, 5.5% had glucose
levels > 11 nmol/l indicating that they had diabetes.
A single fasting glucose sample does not provide
greater sensitivity or speciﬁcity to diagnose diabetes
than a non-fasting sample (19). The gold standard
for testing can be considered the oral glucose toler-
ance test (19). For those with blood glucose levels
between 7.1 and 10.9 mmol/l, an oral glucose toler-
ance test may be considered to conﬁrm whether or
not they have diabetes. Although the percentage with
frank diabetes is only 5.5%, the 6.9% with prediabe-
tes are at signiﬁcantly higher risk of subsequently
developing increased cardiovascular mortality or
morbidity even without the onset of frank diabetes
(20,21). Recent advice emphasises the need for effec-
tive lifestyle interventions in this group (22). This
clearly has major health implications, particularly as
few of the patients were known to be diabetic prior
to entering the programme. The diagnosis of diabetes
is often missed in the SMI population and rates of
known glucose abnormalities (prediabetes in particu-
lar) rise substantially with glucose testing (23–26).
Glucose testing thus identiﬁes a cohort of SMI
patients with prediabetes for whom lifestyle interven-
tions are appropriate (22).
It is well known that patients with long-term men-
tal health problems smoke signiﬁcant amounts of
cigarettes (4,7,8). In this programme, 50% were reg-
ular smokers. The relatively low levels in this study
compared with other studies probably reﬂect the fact
that this was predominantly a community sample
rather than an inpatient sample. Despite smoking less
than an inpatient sample, the rates are high in this
group. Of those that did smoke, most smoked over
20 cigarettes per day. Smoking is a well-known risk
factor for CVD.
A large proportion of the patients in this pro-
gramme had a poor diet and this was associated with
high BMI, lack of exercise and low self esteem.
Improving dietary habits might not only help to
reduce weight but also increase self esteem.
Unsurprisingly, there were high rates of hyperpro-
lactinaemia in the sample. Many datasets on prolac-
tin report only mean data from a population rather
than categorical data. When categorical data are
looked at, at least 38–69% of an SMI population
might be expected to have hyperprolactinaemia, with
factors such as the number of females in the cohort
and the antipsychotics prescribed being important
(27–30). Of concern is that 5% had prolactin levels
over 2000 IU/l, which many clinicians would wish to
investigate further to exclude a prolactin-secreting
tumour (29–31). As these patients were not receiving
regular health checks prior to the WSP, these ﬁnd-
ings were missed. A proportion of this group were
referred for CT or MRI scans to exclude brain
pathology. This ﬁnding indicates a need for more
regular prolactin screening in people who take anti-
psychotic drugs. In addition, hyperprolactinaemia
may be the most important aetiological factor in the
subsequent development of osteoporosis and hip
fractures (32–34).
Almost half the sample had some degree of liver
function abnormality, which indicates a need to
1976 Well-being baseline
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a cholestatic picture which is found in overweight,
but can also be a side effect of antipsychotic medica-
tion. This ﬁnding needs further investigation.
Despite primary care incentives to improve detec-
tion and monitoring of physical disease, generally the
people entering this study were unlikely to have been
receiving regular physical health checks. One of the
problems preventing monitoring is confusion over
whose responsibility it is to do the monitoring. The
UK National Service Framework and NICE guidelines
indicate that primary care should be responsible for
this monitoring and the new GP contract is designed
to facilitate this. However, this audit shows that such
monitoring is not taking place on a regular basis.
There are likely to be a number of complex reasons
for this. A survey by the Mental Health Foundation
revealed that many people with psychiatric illness felt
unable to approach their GP about physical prob-
lems, as they did not believe that they would be taken
seriously (35). Apart from this reason, lack of uptake
of primary care services may be impacted upon by
factors outside of the patient group. Kendrick postu-
lated that GPs may ﬁnd patients with SMI difﬁcult to
communicate with (10). Salmon et al. suggested that
patients with SMI may be harder for the system to
‘process’ because they are chaotic or difﬁcult (36).
Although mental health clinicians are not adequately
trained in chronic physical health assessment and
physical health promotion to be able to provide effec-
tive primary care services, in many cases they may
have more regular contact with SMI clients. There-
fore, mental health clinicians could provide basic
physical health monitoring for cardiovascular risk fac-
tors and facilitate patients with SMI attending pri-
mary care services. The Well-being Support
Programme has developed a training programme to
improve such skills in mental health staff.
These data have shown that in the UK the vast
majority of SMI patients in this chosen cohort have
easily recognisable risk factors for CVD (hyperten-
sion, hyperlipidaemia, obesity, smoking, poor dietary
choices and low exercise levels). Mortality and mor-
bidity in these patients will not begin to decline
unless these issues are appropriately addressed. The
rates of physical health risk factors in this population
are extremely high and are a signiﬁcant public health
issue which needs to be addressed as a matter of
urgency. This group of patients do not have the
same access to physical health care as the rest of the
population. The reason for this inequity of service
needs to be investigated. Evidence should be sought
to ascertain if lifestyle interventions can modify
known physical disease risk factors in the severely
mentally ill.
Limitations
The absence of a population-based control group is a
signiﬁcant limitation in the interpretation of these
data and we cannot be certain as to the extent of
‘hidden’ physical illness and cardiovascular risk fac-
tors present comparatively. Despite full training and
an audit tool into which collected data blood sam-
pling was not complete for all patients. The initial
aim was to collect fasting samples pragmatically,
however, this is not possible easily in an outpatient
SMI cohort with the various limitations including
timing of appointments and laboratory schedules.
Random sampling was thus undertaken. Any inter-
pretation of these data are limited to the chosen
cohort as they cannot be necessarily considered to be
a randomly chosen cohort, chosen however because
of some concern over their physical health monitor-
ing. We also were not able to collect the precise diag-
nosis for each patient nor their medication
schedules. We chose to use the concept of SMI as an
overarching clinical diagnosis as the concept of SMI
is a clinical one and is included in many government
policy documents and other bodies. Most clinicians
understand SMI to include the severe psychoses and
severe affective disorders. This term is used in the
disability rights commission report ‘Equal Treatment,
Closing the Gap’ (37). This report also used the
broadest deﬁnition on mental health problems to
outline the health inequalities between people with
mental health problems and the general public. Our
paper also uses a broad clinical deﬁnition of SMI but
this lack of precision over the exact ICD-10 diagnosis
should be regarded as a limitation in these data. A
ﬁnal limitation is the absence of data on medications
taken by the subjects as these data may have been
helpful in further interpreting the baseline health
data of the subjects.
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